{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:11:11Z","timestamp":1778483471597,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.critrevonc.2026.105301","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:21:09Z","timestamp":1774545669000},"page":"105301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and feasibility of treating adults with paediatric chemotherapy protocols in Ewing sarcoma, rhabdomyosarcoma and osteosarcoma \u2013 A systematic review by the Australia and New Zealand Sarcoma Association clinical practice guidelines working party"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9373-6559","authenticated-orcid":false,"given":"Betty Y.H.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Vrisakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Grimison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Carkeet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek A.","family":"Bhadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne B.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Winstanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah Di-Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smaro","family":"Lazarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Mar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-243X","authenticated-orcid":false,"given":"Angela M.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Cayrol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natacha","family":"Omer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105301_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/681425","article-title":"Adult ewing sarcoma: survival and local control outcomes in 102 patients with localized disease","volume":"2013","author":"Ahmed","year":"2013","journal-title":"Sarcoma"},{"key":"10.1016\/j.critrevonc.2026.105301_bib2","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0959-8049(02)00148-X","article-title":"Neoadjuvant chemotherapy for Ewing\u2019s tumour of bone: recent experience at the Rizzoli Orthopaedic Institute","volume":"38","author":"Bacci","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29081","article-title":"Adolescent-adult nonmetastatic Ewing sarcoma-experience from a large developing country","volume":"68","author":"Bajpai","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12032-019-1282-0","article-title":"Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series","volume":"36","author":"Bergamaschi","year":"2019","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1634\/theoncologist.11-5-503","article-title":"Ewing\u2019s sarcoma family of tumors: current management","volume":"11","author":"Bernstein","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2026.105301_bib6","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1002\/cam4.1374","article-title":"Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study","volume":"7","author":"Bompas","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2026.105301_bib7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(22)01790-1","article-title":"Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial","volume":"400","author":"Brennan","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2026.105301_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114229","article-title":"Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials","volume":"208","author":"Choderlos de Laclos","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib9","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1200\/JCO.2012.43.8598","article-title":"Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis","volume":"31","author":"Collins","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib10","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1097\/MPH.0000000000000339","article-title":"Multimodality treatment of pediatric and adult patients with Ewing sarcoma: a single-institution experience","volume":"37","author":"Diaz-Beveridge","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/cam4.92","article-title":"Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients","volume":"2","author":"Dumont","year":"2013","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2026.105301_bib12","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1038\/s41598-018-27556-1","article-title":"Management of low and intermediate risk adult rhabdomyosarcoma: a pooled survival analysis of 553 patients","volume":"8","author":"Elsebaie","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105301_bib13","unstructured":"eviQ Clinical Practice Guidelines [WWW Document], 2024. \u3008https:\/\/www.eviq.org.au\/medical-oncology\/sarcoma\/bone-sarcoma\/3464-ewing-sarcoma-vdc-ie-overview\u3009 (Accessed 14 December 2025)."},{"key":"10.1016\/j.critrevonc.2026.105301_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/jayao.2020.0043","article-title":"Impact of rhabdomyosarcoma treatment modalities by age in a population-based setting","volume":"10","author":"Ferrari","year":"2021","journal-title":"J. Adolesc. Young Adult Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2352-4642(22)00121-3","article-title":"Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study","volume":"6","author":"Ferrari","year":"2022","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.critrevonc.2026.105301_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cncr.11550","article-title":"Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution","volume":"98","author":"Ferrari","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1179\/joc.2009.21.2.205","article-title":"Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma","volume":"21","author":"Ferrari","year":"2009","journal-title":"J. Chemother."},{"key":"10.1016\/j.critrevonc.2026.105301_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.09.036","article-title":"Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006\/sarcome-09 study","volume":"88","author":"Gaspar","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijrobp.2012.12.016","article-title":"Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols","volume":"86","author":"Gerber","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105301_bib20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/cncr.26358","article-title":"Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children\u2019s Oncology Group Soft Tissue Sarcoma Committee","volume":"118","author":"Gupta","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib21","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/cncr.25144","article-title":"Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy","volume":"116","author":"Gupta","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/402509","article-title":"Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome","volume":"2014","author":"Haddox","year":"2014","journal-title":"Sarcoma"},{"key":"10.1016\/j.critrevonc.2026.105301_bib23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bone.2011.08.014","article-title":"Age as prognostic factor in patients with osteosarcoma","volume":"49","author":"Hagleitner","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.critrevonc.2026.105301_bib24","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.3390\/jcm10163627","article-title":"Age as a prognostic factor in patients with Ewing sarcoma\u2013the Polish sarcoma group experience","volume":"10","author":"Jagodzi\u0144ska-Mucha","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2026.105301_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/pbc.10441","article-title":"Age is an independent prognostic factor in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children\u2019s oncology group","volume":"42","author":"Joshi","year":"2004","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/pbc.20820","article-title":"Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial","volume":"47","author":"Juergens","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ajco.13998","article-title":"Association of chemotherapy dose intensity and age with outcomes in patients with Ewing\u2019s family sarcoma","volume":"21","author":"Klingberg","year":"2023","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00280-012-1920-0","article-title":"Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis","volume":"70","author":"Kojima","year":"2012","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105301_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1634\/theoncologist.2019-0532","article-title":"Feasibility of treating adults with Ewing or Ewing-like sarcoma with interval-compressed vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide and etoposide","volume":"25","author":"Lu","year":"2020","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105301_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2020.03.218","article-title":"Clinical management of adolescents and young adults suffering from sarcoma in the French Rh\u00f4ne-Alpes region: A prospective exhaustive cohort with 10 years follow up","volume":"46","author":"Marec-B\u00e9rard","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib31","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib32","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1111\/ajco.13279","article-title":"The VAC regimen for adult rhabdomyosarcoma: differences between adolescent\/young adult and older patients","volume":"16","author":"Nakano","year":"2020","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/20363613241271669","article-title":"Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: a single-institution cohort","volume":"16","author":"Nakazawa","year":"2024","journal-title":"Rare Tumors"},{"key":"10.1016\/j.critrevonc.2026.105301_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/CAD.0000000000000533","article-title":"Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma","volume":"28","author":"Negr\u00e3o","year":"2017","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.critrevonc.2026.105301_bib35","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.ejca.2006.05.016","article-title":"Childhood soft tissue sarcomas incidence and survival in European children (1978\u20131997): report from the Automated Childhood Cancer Information System project","volume":"42","author":"Pastore","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105301_bib36","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1097\/MPH.0000000000001891","article-title":"Evaluating age-related disparity of outcomes in Ewing sarcoma patients treated at a pediatric academic medical center","volume":"43","author":"Perisa","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/jayao.2011.0027","article-title":"Rhabdomyosarcoma in adolescents and young adults: a 25-year review at nationwide children\u2019s hospital","volume":"1","author":"Streby","year":"2011","journal-title":"J. Adolesc. Young Adult Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib38","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1002\/cam4.4688","article-title":"Comorbidities rather than older age define outcome in adult patients with tumors of the Ewing sarcoma family","volume":"11","author":"Striefler","year":"2022","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2026.105301_bib39","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.3390\/curroncol28060443","article-title":"A retrospective comparative analysis of outcomes and prognostic factors in adult and pediatric patients with osteosarcoma","volume":"28","author":"Testa","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1089\/jayao.2018.0136","article-title":"Management of sarcoma in adolescents and young adults: an Australian population-based study","volume":"8","author":"White","year":"2019","journal-title":"J. Adolesc. Young Adult Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cam4.1898","article-title":"Safety and efficacy of high-dose methotrexate for osteosarcoma in adolescents compared with young adults","volume":"8","author":"Wippel","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2026.105301_bib42","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1200\/JCO.2011.41.5703","article-title":"Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"30","author":"Womer","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105301_bib43","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1186\/s12885-019-6407-5","article-title":"Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:39:51Z","timestamp":1778481591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S1040842826001885"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105301","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and feasibility of treating adults with paediatric chemotherapy protocols in Ewing sarcoma, rhabdomyosarcoma and osteosarcoma \u2013 A systematic review by the Australia and New Zealand Sarcoma Association clinical practice guidelines working party","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105301"}}